Eric Vasiliauskas, MD

Associate Clinical Director, Inflammatory Bowel Disease Center

Eric Vasiliauskas, MD is the Associate Clinical Director of the Inflammatory Bowel Disease Center at Cedars-Sinai and a member of the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute.

Dr. Vasiliauskas has long recognized the existence of subgroups within Crohn’s disease and ulcerative colitis and how these important subtleties influence disease expression, disease course, responses to traditional medical and surgical interventions, as well as to dietary and other alternative approaches. He has thus been a longtime proponent of personalized medicine and individualized therapy in IBD.

Frequently referred to as “Dr. V”, Dr. Vasiliauskas has been described as “a diet-friendly doctor” and is a strong advocate of living a healthy lifestyle. He recognizes the significant potential benefits of both traditional and nontraditional approaches to IBD care, while at the same time also acknowledging the shortcomings of each approach practiced in isolation. Throughout his career, Dr. Vasiliauskas has been open to incorporating a broad spectrum of nontraditional options to help patients fine-tune their health to wellness. He is a firm believer that a complementary or integrative approach to IBD management optimizes desired outcomes, well-being and quality of life.

In his role as director of the Cedars-Sinai Nutrition & Integrative IBD Subspecialty Clinic, Dr. Vasiliauskas continues to explore the role of a variety of dietary manipulations and other nontraditional interventions in the management of Crohn’s disease, ulcerative colitis, IBD-associated small intestinal bacterial overgrowth, lymphocytic and collagenous colitis. In partnership with his patients, he continues to examine the influences of diet and supplements on disease activity and specific symptoms, including the impact on extra-intestinal manifestations of IBD, such as joint involvement, mouth ulcerations, etc. In collaboration with his colleagues, Dr. Vasiliauskas is leading efforts to investigate the short-term and long-term affects of specific nutritional modifications on the gut microbiome and on epigenetic influences with the goal of augmenting our understanding of the complex interplay between diet, the gut microbiome, disease activity and expression.

Dr. Vasiliauskas serves as the principal investigator or co-investigator on numerous research studies at Cedars-Sinai. He has been involved in pioneering the use of a variety of novel therapeutics in IBD, including biologic therapies (infliximab, adalimumab, certolizumab, natalizumab, and vedolizumab), thalidomide, and placental stem cell therapy. His research has also included investigations of the potential applications of serum immune and genetic markers as well as other endoscopic and imaging techniques, including wireless capsule enteroscopy, double-balloon enteroscopy, ultrasound, and CT and MRI enterography in IBD.

Dr. Vasiliauskas has served on both the Professional Education Committee and the Patient Education Committee of the Crohn's and Colitis Foundation of America (CCFA), as well as the Pediatric IBD Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). He is also a member of the American Gastroenterological Association. He has written numerous articles for such peer-reviewed publications as Gastroenterology, Gut, Diseases of the Colon and Rectum, Digestive Diseases and Sciences, Inflammatory Bowel Diseases, American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and others.

Dr. Vasiliauskas earned his bachelor's degree from the University of Illinois, Champaign-Urbana and his medical degree from the University of Illinois College of Medicine in Rockford. After a general pediatrics internship and residency at Children's Hospital Los Angeles, Dr. Vasiliauskas completed a pediatric gastroenterology and nutrition fellowship at Children's Hospital, Cedars-Sinai, Los Angeles County-University of Southern California Medical Center, Harbor-UCLA Medical Center and at Martin Luther King, Jr./Charles R. Drew Medical Center in Los Angeles. He completed a two-year fellowship specifically in inflammatory bowel disease at Cedars-Sinai. He is an Associate Professor of Medicine and Pediatrics at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).

Click here for a list of Dr. Vasiliauskas' research articles.